Upregulation of Mad2 facilitates in vivo and in vitro osteosarcoma progression

N/ACitations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

It has been reported that overexpression of Mad2 in transgenic mice leads to a wide variety of tumors, and Mad2 overexpression causes lung tumor relapse after oncogene withdrawal. In a previous study we demonstrated that Mad2 is abnormally upregulated in human osteosarcoma, however, the underlying mechanisms remain unknown. In this study, we found that transient Mad2 overexpression is sufficient to cause early dyscrasia and decreased survival in a xenotransplantation osteosarcoma mouse model, and Mad2 overexpression is associated with increased invasiveness and pulmonary metastasis. We also found that upregulation of Mad2 was accompanied by enhanced capability to self-renew. Our data validate the correlation between upregulation of Mad2 and osteosarcoma advancement, and that the underlying mechanisms involve the increase of invasiveness and cancer stem cell properties.

Cite

CITATION STYLE

APA

Yu, L., Liu, S., Guo, W., Zhang, B., Liang, Y., & Feng, Q. (2012). Upregulation of Mad2 facilitates in vivo and in vitro osteosarcoma progression. In Oncology Reports (Vol. 28, pp. 2170–2176). https://doi.org/10.3892/or.2012.2032

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free